Naami Nibras, Borkhardt Arndt, Yoshimi Ayami, Grinstein Lev, Escherich Gabriele
Department of Pediatric Oncology, Hematology and Clinical Immunology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Department of Pediatric Hematology and Oncology, University of Freiburg, Freiburg, Germany.
Am J Hematol. 2022 Nov;97(11):1495-1496. doi: 10.1002/ajh.26573. Epub 2022 May 6.
We diagnosed a 13-month-old girl with severe neurological deficits and hyporegenerative macrocytic anemiawith Brown-Vialetto-Van Laere syndrome type 2 (BVVL 2), a rare disorder of the riboflavin transporter, caused by variants in the SLC52A2 gene. Bone marrow aspiration revealed hypoplastic erythropoiesis and vacuolization of myelocytes, proerythroblasts, and micromegakaryocytes. We suggest BVVL 2 as an important differential diagnosis in hyporegenerative macrocytic anemia as rapid diagnosis and initiation of therapy are crucial for the remedy of hematological and neurological impairment.
我们诊断一名13个月大的女童患有严重神经功能缺损和再生低下性大细胞贫血,其患有2型布朗-维阿莱托-范莱尔综合征(BVVL 2),这是一种由SLC52A2基因突变导致的罕见核黄素转运蛋白疾病。骨髓穿刺显示红细胞生成减少以及髓细胞、早幼红细胞和微巨核细胞空泡化。我们建议将BVVL 2作为再生低下性大细胞贫血的一项重要鉴别诊断,因为快速诊断和开始治疗对于纠正血液学和神经学损伤至关重要。